United States

Top 538 largest US Companies in the Biotechnology industry by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry from the United States by market capitalization with links to their reference stock.

United States Biotechnology Industry Analysis
Top US Companies United States Analysis
World Top Companies World Companies Analysis

Top Biotechnology Companies from the United States as of Jul. 01, 2024

Download Excel

Rank Company Market Cap (USD) Country Sector Industry
331 Vor Biopharma, Inc. $61.4 M United States US Healthcare US Biotechnology
332 Surface Oncology, Inc. $59.2 M

(July 1, 2023)

United States US Healthcare US Biotechnology
333 Anebulo Pharmaceuticals, Inc. $58.4 M United States US Healthcare US Biotechnology
334 Passage Bio, Inc. $56.5 M United States US Healthcare US Biotechnology
335 HOOKIPA Pharma Inc. $55.9 M United States US Healthcare US Biotechnology
336 Artemis Therapeutics, Inc. $55.8 M

(May 1, 2023)

United States US Healthcare US Biotechnology
337 Cidara Therapeutics, Inc. $55.0 M United States US Healthcare US Biotechnology
338 Eyenovia, Inc. $53.6 M United States US Healthcare US Biotechnology
339 Tyme Technologies, Inc. $53.5 M

(Sept. 1, 2022)

United States US Healthcare US Biotechnology
340 Sigilon Therapeutics, Inc. $53.3 M

(July 1, 2023)

United States US Healthcare US Biotechnology
341 Ovid Therapeutics Inc. $52.9 M United States US Healthcare US Biotechnology
342 Reneo Pharmaceuticals, Inc. $50.7 M United States US Healthcare US Biotechnology
343 Aeglea BioTherapeutics, Inc. $48.6 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
344 BioVie Inc. $48.3 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
345 Cue Biopharma, Inc. $46.7 M United States US Healthcare US Biotechnology
346 Cyclo Therapeutics, Inc. $45.2 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
347 Fortress Biotech, Inc. $44.5 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
348 Lantern Pharma Inc. $44.4 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
349 Eledon Pharmaceuticals, Inc. $44.3 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
350 Atara Biotherapeutics, Inc. $44.2 M United States US Healthcare US Biotechnology
351 Dyadic International, Inc. $44.2 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
352 Rain Therapeutics, Inc. $43.7 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
353 Kezar Life Sciences, Inc. $42.2 M United States US Healthcare US Biotechnology
354 Ocuphire Pharma, Inc. $39.5 M United States US Healthcare US Biotechnology
355 BioXcel Therapeutics, Inc. $39.4 M United States US Healthcare US Biotechnology
356 Curis, Inc. $37.6 M United States US Healthcare US Biotechnology
357 Aligos Therapeutics, Inc. $37.0 M United States US Healthcare US Biotechnology
358 BeyondSpring Inc. $36.2 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
359 Reviva Pharmaceuticals Holdings, Inc. $35.8 M United States US Healthcare US Biotechnology
360 Longeveron, Inc. $32.4 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology

Top Biotechnology Companies from the United States as of Jul. 01, 2024

331. Vor Biopharma, Inc.

Company Profile: Vor Biopharma, Inc.
Market Cap (USD): $61.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

332. Surface Oncology, Inc.

Company Profile: Surface Oncology, Inc.
Market Cap (USD): $59.2 M (July 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

333. Anebulo Pharmaceuticals, Inc.

Company Profile: Anebulo Pharmaceuticals, Inc.
Market Cap (USD): $58.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

334. Passage Bio, Inc.

Company Profile: Passage Bio, Inc.
Market Cap (USD): $56.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

335. HOOKIPA Pharma Inc.

Company Profile: HOOKIPA Pharma Inc.
Market Cap (USD): $55.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

336. Artemis Therapeutics, Inc.

Company Profile: Artemis Therapeutics, Inc.
Market Cap (USD): $55.8 M (May 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

337. Cidara Therapeutics, Inc.

Company Profile: Cidara Therapeutics, Inc.
Market Cap (USD): $55.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

338. Eyenovia, Inc.

Company Profile: Eyenovia, Inc.
Market Cap (USD): $53.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

339. Tyme Technologies, Inc.

Company Profile: Tyme Technologies, Inc.
Market Cap (USD): $53.5 M (Sept. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

340. Sigilon Therapeutics, Inc.

Company Profile: Sigilon Therapeutics, Inc.
Market Cap (USD): $53.3 M (July 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

341. Ovid Therapeutics Inc.

Company Profile: Ovid Therapeutics Inc.
Market Cap (USD): $52.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

342. Reneo Pharmaceuticals, Inc.

Company Profile: Reneo Pharmaceuticals, Inc.
Market Cap (USD): $50.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

343. Aeglea BioTherapeutics, Inc.

Company Profile: Aeglea BioTherapeutics, Inc.
Market Cap (USD): $48.6 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

344. BioVie Inc.

Company Profile: BioVie Inc.
Market Cap (USD): $48.3 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

345. Cue Biopharma, Inc.

Company Profile: Cue Biopharma, Inc.
Market Cap (USD): $46.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

346. Cyclo Therapeutics, Inc.

Company Profile: Cyclo Therapeutics, Inc.
Market Cap (USD): $45.2 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

347. Fortress Biotech, Inc.

Company Profile: Fortress Biotech, Inc.
Market Cap (USD): $44.5 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

348. Lantern Pharma Inc.

Company Profile: Lantern Pharma Inc.
Market Cap (USD): $44.4 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

349. Eledon Pharmaceuticals, Inc.

Company Profile: Eledon Pharmaceuticals, Inc.
Market Cap (USD): $44.3 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

350. Atara Biotherapeutics, Inc.

Company Profile: Atara Biotherapeutics, Inc.
Market Cap (USD): $44.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

351. Dyadic International, Inc.

Company Profile: Dyadic International, Inc.
Market Cap (USD): $44.2 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

352. Rain Therapeutics, Inc.

Company Profile: Rain Therapeutics, Inc.
Market Cap (USD): $43.7 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

353. Kezar Life Sciences, Inc.

Company Profile: Kezar Life Sciences, Inc.
Market Cap (USD): $42.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

354. Ocuphire Pharma, Inc.

Company Profile: Ocuphire Pharma, Inc.
Market Cap (USD): $39.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

355. BioXcel Therapeutics, Inc.

Company Profile: BioXcel Therapeutics, Inc.
Market Cap (USD): $39.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

356. Curis, Inc.

Company Profile: Curis, Inc.
Market Cap (USD): $37.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

357. Aligos Therapeutics, Inc.

Company Profile: Aligos Therapeutics, Inc.
Market Cap (USD): $37.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

358. BeyondSpring Inc.

Company Profile: BeyondSpring Inc.
Market Cap (USD): $36.2 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

359. Reviva Pharmaceuticals Holdings, Inc.

Company Profile: Reviva Pharmaceuticals Holdings, Inc.
Market Cap (USD): $35.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

360. Longeveron, Inc.

Company Profile: Longeveron, Inc.
Market Cap (USD): $32.4 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology